PharmaCorp Rx Inc. Reports Impressive Q3 2025 Financial Outcomes
SASKATOON, Saskatchewan – PHARMACORP RX INC. (TSXV:PCRX), a prominent platform focused on pharmacist-led community pharmacy ownership, recently shared its financial performance for the three and nine months concluded on September 30, 2025. The quarter showcased momentum in operations, with substantial financial growth from individual pharmacy locations.
Financial Highlights from Q3 2025
The third quarter reflected a significant upturn in operational efficiency and profitability across the company's pharmacy locations. The increase in revenues was largely attributed to a rise in prescription volumes and front-of-store sales. Q3 2025 Financial Highlights include the following:
- Continuous increase in prescription volumes and front-store sales
- Same-store sales rose by 9.4% year-over-year compared to the previous year, indicating organic growth across the network
- Total prescription count saw a rise of 7.2% year-over-year, suggesting robust patient engagement
- Infrastructure investments were made to support national scalability, focusing on systems integration and pharmacy onboarding
- The net loss recorded was a result of continued investment in corporate infrastructure among other factors
- Strong pharmacy contribution margins underline PharmaCorp's strategy for accretive growth
Management Insights on Company Progress
Alan Simpson, Executive Chairman of PharmaCorp, expressed optimism about the company's trajectory. He stated, "The initial acquisitions show encouraging performance and demonstrate our steady progress in scaling the business. We are dedicated to maintaining a strong EBITDA multiple, reinforcing our goal of achieving sustainable growth across our acquisitions." This vision underlines the company's commitment to building a robust pharmacy network.
Investments and Growth Strategy
During this quarter, PharmaCorp invested significantly in essential systems and personnel to facilitate a scalable national growth strategy. The reported net loss includes options granted to directors and officers, alongside legal fees incurred from securing a credit facility.
Key Developments Post-Quarter
Shortly after the quarter-end, PharmaCorp expanded its portfolio through significant acquisitions. It purchased 100% interests in two pharmacies located in different regions, marking an ambitious move towards broadening its operational footprint. The acquisition involved investments totaling approximately $8.7 million, funded through a mix of cash and funds from the credit facility.
Recent Financial Initiatives
In November, PharmaCorp successfully closed a bought deal public offering co-led by investment firms, raising about C$23.0 million. The funds raised will bolster the company’s capacity for future acquisitions and support ongoing operational consistency.
Sustaining Operational Benefits
This release also acknowledges the term “same-store sales,” integral for assessing ongoing operational performance. This measure aids in observing trends that may not be visible through traditional financial metrics, allowing the company to share a clearer picture of its performance with investors.
About PharmaCorp Rx Inc.
PharmaCorp is committed to empowering pharmacists by facilitating their ownership in community pharmacies. The company operates under the PharmaChoice Canada banner and aims to form lasting partnerships with pharmacy owners considering exits from their businesses.
Contact Information
For further inquiries about PharmaCorp’s initiatives or acquisition strategies, interested parties can reach out through the following contact:
Investor Relations
info@pharmacorprx.ca
Tel: (306) 536-3771
Frequently Asked Questions
What is PharmaCorp Rx Inc. known for?
PharmaCorp Rx Inc. is a pharmacy acquisition platform focusing on pharmacist-led community pharmacy ownership.
What were the financial highlights for Q3 2025?
The company recorded significant growth in revenues, same-store sales, and total prescription volumes, indicating strong performance.
How does PharmaCorp support pharmacy owners?
PharmaCorp provides capital and strategic support to empower pharmacists and assists retiring owners through seamless transitions.
What recent acquisitions has PharmaCorp made?
PharmaCorp acquired pharmacies in Western and Eastern Canada, enhancing its national presence and operational scale.
How can investors get more information?
Investors can contact PharmaCorp through their website or via their investor relations email for detailed discussions.
